Endo-lysosomal patch clamp assay

Overview

The endo-lysosomal system is a series of intracellular organelles responsible for recycling and degradation of macromolecules. Endo-lysosomes express several functionally diverse ion channels, crucial for regulating organelle trafficking and intracellular signalling as well as maintaining the acidic luminal pH for optimal enzymatic activity. Dysfunctions within the endo-lysosomal system are associated with multiple disorders including lysosomal storage disorders and neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Lysosomal ion channels have therefore gained significant attention as potential targets for novel therapeutics.

Due to their localisation to small intracellular compartments, endo-lysosomal ion-channels have been historically challenging to study using conventional patch-clamp techniques. However, recent advances in lysosomal biology make it possible to enlarge and extract endo-lysosomes for subsequent recording using manual patch-clamp electrophysiology. This approach allows for the characterization of channel function within the native environment, facilitating better physiological understanding.

Endo-lysosomal extraction technique

  • Cells are incubated for at least 2 h with vacuolin-1 to enlarge endo-lysosomes.
  • Prior to recordings, cells are briefly incubated with neutral red to visualise acidic intracellular compartments.
  • A small diameter glass pipette is used to rupture the cell and to excise enlarged endo-lysosomes.
  • Isolated endo-lysosomes are subsequently patched using a fresh, fire polished glass pipette.
image
Figure 1. Schematic illustrating lysosomal patch clamp technique

TRPML1 case study

Transient receptor potential mucolipin 1 (TRPML1), is Ca2+ permeable, nonselective cation channel, expressed in late endosomes and lysosomes. TRPML1 is a key regulator for multiple cellular functions including lysosomal signalling, autophagy, and membrane trafficking. Mutations in MCOLN1, encoding TRPML1, cause mucolipidosis type IV, a severe autosomal recessive lysosomal storage disorder, characterised by diverse symptoms including delayed psychomotor development and ocular aberrations. TRPML1 has further been implicated in the pathogenesis of Alzheimer’s disease and other neurodegenerative disorders, making it an attractive target for drug discovery.

TRPML1 is regulated by pH, with the highest activity under acidic conditions as found in the lysosomal lumen (Figure 2). In this example, experiments were performed in whole cell configuration on the manual patch clamp platform using a variant lacking the organelle targeting motif (TRPML1-4A), that can be expressed at the plasma membrane and would therefore also be suitable for high throughput screening.

pH dependence of TRPML1-4A activation – whole cell recordings

image 5
Figure 2a. TRPML1-4A current traces at decreasing extracellular pH values
image 2
Figure 2b. ML-SA1 induced TRPML1-4A activation increases with acidic pH

 

To investigate these channels in their native environment, we established a refined manual patch clamp technique to directly record from isolated endo-lysosomes, suitable for investigating potential therapeutic agents as exemplified in the example shown in Figure 3.

 

ML-SA1 concentration-response -endo-lysosomal recordings

image 3
Figure 3a. Representative current traces showing ML-SA1 induced currents in endo-lysosomes
image 4
Figure 3b. ML-SA1 concentration response curve from endo-lysosomes
Recommended Publications
Latest Publications
Development of TRPML1-4A assays across manual, automated patch-clamp, and fluorescence-based platforms

The development and validation of electrophysiological assays to study TRPML1 is important to understand the function and pharmacology of the channel. We used a TRPML1 variant that lacks the endo-lysosomal retention sequences (TRPML1-4A), enabling the channel to express at the plasma membrane3. As such channel behaviour can be characterised by means of whole-cell patch-clamp and fluorescence-based techniques.

GLP hERG screening assay validation following ICH E14/S7B 2022 Q&A best practice guidelines

The ICH E14/S7B 2022 Q&As stipulate that in vitro hERG assessments should be conducted in accordance with Good Laboratory Practice (GLP). We present a GLP compliant study using the conventional manual patch-clamp technique in accordance with the ICH E14/S7B Q&A best practice guidelines to establish in-house IC50 values for ondansetron, moxifloxacin and dofetilide.

View All
Metrion Biosciences

Let’s work together

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.
Contact us for a quote or discussion
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram